NDC 11822-4530-07 - Sinus Pressure and Congestion Relief PE Maximum Strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 11822-4530
- Requested NDC
- 11822-4530-07
- Package NDCs from labels
- 11822-4530-4, 11822-4530-7, 11822-4530-2, 11822-4530-07
- Manufacturer
- Rite Aid Corporation | LNK International, Inc.
- Effective date
- 2026-05-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Rite Aid 44-453 | Rite Aid Corporation | LNK International, Inc. | 2026-05-01 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 11822-4530-2 | Sinus Pressure and Congestion Relief PEMaximum Strength | 3 in 1 CARTON | TABLET, FILM COATED | 3 | 20 | |
| 11822-4530-2 | Sinus Pressure and Congestion Relief PEMaximum Strength | 24 in 1 BLISTER PACK | TABLET, FILM COATED | 24 | 20 | |
| 11822-4530-4 | Sinus Pressure and Congestion Relief PEMaximum Strength | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 20 | |
| 11822-4530-4 | Sinus Pressure and Congestion Relief PEMaximum Strength | 18 in 1 BLISTER PACK | TABLET, FILM COATED | 18 | 20 | |
| 11822-4530-7 | Sinus Pressure and Congestion Relief PEMaximum Strength | 18 in 1 BLISTER PACK | TABLET, FILM COATED | 18 | 20 | |
| 11822-4530-7 | Sinus Pressure and Congestion Relief PEMaximum Strength | 2 in 1 CARTON | TABLET, FILM COATED | 2 | 20 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 11822-4530 | SINUS PRESSURE AND CONGESTION RELIEF PE MAXIMUM STRENGTH (PHENYLEPHRINE HCL) TABLET, FILM COATED [RITE AID CORPORATION] | 19 | Current NDC, Legacy NDC, 6 package rows | 20250512_fccea3c5-42af-4939-82bc-d9409b75f91f.zip |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Exchange Select Cough Drops Original Herb | MENTHOL | Army & Air Force Exchange Service | 3d7109a5-4fe1-039b-e063-6394a90a1392 | 2025-08-28 | Warnings | M012 |
| MGC Health Cough Drops Honey Herb | MENTHOL | Medical Group Care LLC | 3d710deb-e42d-13eb-e063-6394a90a56e1 | 2025-08-28 | Warnings | M012 |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 2 | ENSULIZOLE,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3d55291c-9d4c-85c3-e063-6394a90af330 | 2025-08-27 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 3 | ENSULIZOLE ,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Hangzhou Jingshen Trading Co., Ltd. | 3d565612-ade5-bfb3-e063-6294a90a0c65 | 2025-08-27 | Warnings | 15FIX9V2JP |
| Sun Bum 30 Mineral Tinted Sunscreen Face | TITANIUM DIOXIDE, ZINC OXIDE | Sun Bum, LLC | 3a290aad-7f40-cb10-e063-6394a90a2e69 | 2025-08-27 | Warnings | 15FIX9V2JP |
| Sinus Relief Pressure and Pain | ACETAMINOPHEN, GUAIFENESIN, PHENYLEPHRINE HCL | Kroger Company | 98de5cff-3ff5-49b0-bef9-5b9ebb86491e | 2025-08-27 | Warnings | M012 04JA59TNSJ |
| Nighttime SEVERE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HYDROCHLORIDE | H E B | 0a178114-0748-4a92-9b60-a7a0a8b72287 | 2025-08-26 | Warnings | M012 04JA59TNSJ |
| Dextrose and Sodium Chloride | DEXTROSE AND SODIUM CHLORIDE | Baxter Healthcare Company | dcbf1907-1841-4afc-ab5d-a9893a2d7256 | 2025-08-26 | Warnings, Adverse reactions | LX22YL083G |
| Adult Bisolvine Adult | GUAIFENESIN, DEXTROMETHORPHAN | MENPER DISTRIBUTORS INC. | 8cde5e39-a338-45af-b847-3823627f29c5 | 2025-08-25 | Warnings | M012 |
| Pain Reliever PM Extra Strength | ACETAMINOPHEN, DIPHENHYDRAMINE HCL | Strategic Sourcing Services LLC | 997eb228-09cb-47ad-acbb-363b05c67635 | 2025-08-25 | Warnings | M012 |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 6 | ENSULIZOLE ,HOMOSALATE ,OCTINOXATE,TITANIUM DIOXIDE | Longway Technology(Guangzhou) Co., Ltd. | 3d0359b6-088f-aa54-e063-6394a90a422f | 2025-08-23 | Warnings | 15FIX9V2JP |
| SanaTos Multi Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCI | Pharmadel LLC | df260190-89e7-b338-e053-2995a90a32cb | 2025-08-22 | Warnings | M012 04JA59TNSJ |
| Geri-Dryl allergy relief | DIPHENHYDRAMINE HCL | VerityRx | 9ca6c0f8-71d1-4953-8e98-3311c4664011 | 2025-08-22 | Warnings | M012 |
| SU PHEDRINE PE Non-Drowsy, Maximum Strength | PHENYLEPHRINE HCL | Salado Sales, Inc. | 9056fa58-d6aa-4df5-97e0-9be3f2332f86 | 2025-08-22 | Warnings | M012 1049182 04JA59TNSJ |
| Refresh RELIEVA PF | CARBOXYMETHYLCELLULOSE SODIUM AND GLYCERIN | Allergan, Inc. | d5d3df4a-a311-4f2d-9a24-edfec1a6c9f9 | 2025-08-22 | Warnings | K679OBS311 |
| Refresh Optive | CARBOXYMETHYLCELLULOSE SODIUM, GLYCERIN | Allergan, Inc. | 37e99aa8-02d6-4efb-a862-90bc7fcd5ca5 | 2025-08-22 | Warnings | K679OBS311 |
| Exchange Select Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Army & Air Force Exchange Service | 6c32af3e-5b60-4e3e-95c2-ada37a7d3b2a | 2025-08-22 | Warnings | 04JA59TNSJ |
| Hemorrhoidal | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Padagis Israel Pharmaceuticals Ltd | 43826c68-0a20-460d-a7b5-f3e12395a7d0 | 2025-08-22 | Warnings | 04JA59TNSJ |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 4 | ENSULIZOLE,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Longway Technology(Guangzhou) Co., Ltd. | 3cdc1ae9-2924-5057-e063-6294a90ad2f3 | 2025-08-21 | Warnings | 15FIX9V2JP |
| PHOFAY Matte Sunscreen Liquid Foundation SPF 30 3 | ENSULIZOLE,HOMOSALATE,OCTINOXATE,TITANIUM DIOXIDE | Longway Technology(Guangzhou) Co., Ltd. | 3b21f1d8-534d-f4ea-e063-6294a90ad2eb | 2025-08-21 | Warnings | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.